首页|嵌合抗原受体T细胞的肿瘤杀伤作用

嵌合抗原受体T细胞的肿瘤杀伤作用

扫码查看
近年来,嵌合抗原受体T(chimeric antigen receptor T,CAR-T)细胞免疫疗法在血液恶性肿瘤的治疗中取得了重要进展,但在实体瘤方面的应用并不理想.本文对CAR-T细胞的结构、杀伤功能进行了介绍,包括非经典免疫突触的形成、分泌细胞因子、分泌穿孔素和颗粒酶、Fas-FasL(factor associated suicide-Fas ligand)途径以及组成CAR结构成分的改变等杀伤肿瘤的主要机制,比较三种CAR细胞的特点,结合CAR-T细胞治疗实体瘤的挑战,对CAR-T细胞在肿瘤免疫治疗领域未来的研究方向进行了分析.
Tumor-Killing Effects of Chimeric Antigen Receptor T Cells
In recent years,significant progress has been made in the field of chimeric antigen re-ceptor T(CAR-T)cell immunotherapy for the treatment of hematologic malignancies,while its application in solid tumors has proven to be less than optimal.This article provides an introduc-tion to the structure and function of CAR-T cells,encompassing key mechanisms underlying tumor cytotoxicity such as the formation of non-classical immune synapses,cytokine secretion,perforin and granzyme release,the Fas(factor-associated suicide)-FasL(Fas ligand)pathway,and alterations in the components constituting the CAR structure.The features of three CAR cell types are compared,and in light of the challenges associated with CAR-T cell therapy for solid tumors,the article analyzes future research directions for CAR-T cells in the field of cancer im-munotherapy.

chimeric antigen receptor T-celltumorimmunotherapycytotoxic functionre-search progress

黄凯锋、王月丹、李海潮

展开 >

北京大学第一医院呼吸与危重症医学科,北京 100034

北京大学基础医学院免疫学系,北京 100191

嵌合抗原受体T细胞 肿瘤 免疫治疗 杀伤功能 研究进展

科技部国家重点研发计划"战略性科技创新合作"重点专项

SQ2021YFE020462

2024

生理科学进展
中国生理学会,北京大学

生理科学进展

CSTPCD北大核心
影响因子:0.635
ISSN:0559-7765
年,卷(期):2024.55(4)